SEARCH

SEARCH BY CITATION

References

  • 1
    Peiris JSM, Lai ST, Poon LLM et al. Severe acute respiratory syndrome (SARS) is associated with a coronavirus. Lancet 2003; 361: 131925.
  • 2
    Lee N, Hui D, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 198694.
  • 3
    Booth CM, Matukas LM, Tomlinson GA et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 2003; 289: 28019.
  • 4
    Anonymous. Outbreak of severe acute respiratory syndrome - worldwide, 2003. MMWR 2003; 52: 2268.
  • 5
    World Health Organization. Severe acute respiratory syndrome (SARS) – multi-country outbreak – update 49. http://www.who.int/csr/don/2003_05_07a/en/ (accessed 19 May 2003).
  • 6
    Cui W, Fan Y, Wu W et al. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin Infect Dis 2003; 37: 8579.
  • 7
    World Health Organization. Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003; 78: 813.
  • 8
    Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet 2003; 361: 4867.
  • 9
    World Health Organization. PCR primers for SARS developed by WHO Network Laboratories. http://www.who.int/csr/sars/primers/en/print/html (accessed 20 September 2003).
  • 10
    Wong GWK, Hui DSC. Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management. Thorax 2003; 58: 55860.
  • 11
    Chan MHM, Chow KM, Chan ATC et al. Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusions. Clin Chem 2003; 49: 7405.
  • 12
    Choi KW, Chau TN, Tsang O et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003; 139: 71523.
  • 13
    Chan JWM, Ng CK, Chan YH et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58: 6869.
  • 14
    Lott JA, Nemesánszky E. Lactate dehydrogenase. In: LottJA, WolfPL, eds. Clinical Enzymology: A Case-orientated Approach. New York: Field, Rich and Associates, Inc., 1986; 2279.
  • 15
    Onigbinde TA, Wu AH, Johnson M et al. Clinical evaluation of an automated chemical inhibition assay for lactate dehydrogenase isoenzyme 1. Clin Chem 1990; 36: 181922.
  • 16
    Tsui PT, Kwok ML, Yuen H et al. Severe acute respiratory syndrome: clinical outcomes and prognostic correlates. Emerg Infect Dis 2003; 9: 10649.
  • 17
    Wong CK, Lam CWK, Wu AKL et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004; 136: 95103.
  • 18
    Yuen KY, Chan PKS, Peiris M et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 46771.
  • 19
    Rimmelzwaan GF, Kuiken T, van Amerongen G et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001; 75: 668191.
  • 20
    Tumpey TM, Lu X, Morken T et al. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000; 74: 610516.
  • 21
    De Franceschi L, Fattovich G, Turrini F et al. Haemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000; 31: 9971004.
  • 22
    Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS) – Is the use of ribavirin (or other antiviral drugs) effective in the treatment of patients with SARS? http://www.cdc.gov/ncidod/sars/qa/illness.htm (accessed24 May 2003).
  • 23
    Knowles SR, Phillips EJ, Dresser L et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis 2003; 37: 113942.
  • 24
    Wong RSM, Wu A, To KF et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003; 326: 135862.
  • 25
    Mandy FF, Nicholson JKA, McDougal JS. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5202a1.htm (accessed 24 May 2003).
  • 26
    Lapinsky SE, Hawryluck L. ICU management of severe acute respiratory syndrome. Intensive Care Med 2003; 29: 8705.
  • 27
    Hannet I, Erkeller-Yuksel F, Lydyard P et al. Developmental and maturational changes in human blood lymphocyte populations. Immunol Today 1992; 13: 2158.